FDA Inspection
Lonza Biologics, Inc.Lonza Biologics, Inc. – FDA Inspection, Jul 21, 2023
Record Details
This FDA Inspection record concerns Lonza Biologics, Inc., with an inspection on July 21, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · fa6c0e5e-762e-44f9-b5cd-483c8003242f
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1210690
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Lonza Biologics, Inc.
12| Date | Classification | Office | Project area |
|---|---|---|---|
| April 16, 2026 | Not classified | New England District Office | Blood and Blood Products |
| February 6, 2026 | Not classified | New England District Office | |
| June 6, 2025 | Not classified | New England District Office | |
| July 12, 2024 | Not classified | New England District Office | |
| March 7, 2024 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
Other documents for Lonza Biologics, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.